Comparative Effects on Intestinal Absorption in Situ by P-glycoprotein-Modifying HIV Protease Inhibitors

This publication has 17 references indexed in Scilit:

• Dimeric 4-Aryl-1,4-Dihydropyridines: Development of a Third Class of Nonpeptidic HIV-1 Protease Inhibitors
  Mini-Reviews in Medicinal Chemistry, 2002
• Comparison of Furosemide and Vinblastine Secretion from Cell Lines Overexpressing Multidrug Resistance Protein (P-Glycoprotein) and Multidrug Resistance-Associated Proteins (MRP1 and MRP2)
  Pharmacology, 2002
• Pharmazeutisch-technologische und biopharmazeutische Aspekte bei HIV-Protease-Inhibitoren: Formulierung von IV-Protease-Hemmern
  Pharmazie in unserer Zeit, 2001
• Dimeric 4-aryl-1,4-dihydropyridines as novel HIV-1 protease inhibitors--affinities to intestinal P-glycoprotein.
  2000
• Interactions of HIV Protease Inhibitors with ATP-Dependent Drug Export Proteins
  Molecular Pharmacology, 1999
• HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833
  Biochemical Pharmacology, 1999
• Mechanisms and timing of mother-to-child transmission of HIV-1
  AIDS, 1998
• P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound.
  1998
• Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein
  British Journal of Cancer, 1997
• Current Knowledge and Future Prospects for the Use of HIV Protease Inhibitors
  Drugs, 1996